Skip to content
6-K

Foreign Interim / Material

CLEMENTIA PHARMACEUTICALS INC.

0001171843-18-007671

← back to feed
Filed
Nov 7, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow Q3 2018 · Sep 30, 2018 −$12.65M
Operating Cash Flow Q3 2018 · Sep 30, 2018 −$36.15M
Operating Cash Flow Q3 2018 · Dec 31, 2017 −$35.57M
Operating Cash Flow Q3 2018 · Sep 30, 2017 −$12.17M
Operating Cash Flow Q3 2018 · Sep 30, 2017 −$24.31M
Cash And Equivalents Q3 2018 · Sep 30, 2018 $12.06M
Cash And Equivalents Q3 2018 · Jun 30, 2018 $12.94M
Cash And Equivalents Q3 2018 · Dec 31, 2017 $36.23M
Cash And Equivalents Q3 2018 · Sep 30, 2017 $37.24M
Cash And Equivalents Q3 2018 · Jun 30, 2017 $11.58M
Cash And Equivalents Q3 2018 · Dec 31, 2016 $9.43M
Stockholders Equity Q3 2018 · Sep 30, 2018 $106.59M
Stockholders Equity Q3 2018 · Dec 31, 2017 $141.71M
Stockholders Equity Q3 2018 · Sep 30, 2017 $152.79M
Stockholders Equity Q3 2018 · Dec 31, 2016 −$148.67M
Total Liabilities Q3 2018 · Sep 30, 2018 $8.79M
Total Liabilities Q3 2018 · Dec 31, 2017 $6.72M
Current Assets Q3 2018 · Sep 30, 2018 $88.06M
Current Assets Q3 2018 · Dec 31, 2017 $70.9M
Total Assets Q3 2018 · Sep 30, 2018 $115.38M
Total Assets Q3 2018 · Dec 31, 2017 $148.43M
Rd Expense Q3 2018 · Sep 30, 2018 $10.69M
Rd Expense Q3 2018 · Sep 30, 2018 $29.12M
Rd Expense Q3 2018 · Sep 30, 2017 $7.07M
Rd Expense Q3 2018 · Sep 30, 2017 $16.81M
Net Income Q3 2018 · Sep 30, 2018 −$14.78M
Net Income Q3 2018 · Sep 30, 2018 −$38.78M
Net Income Q3 2018 · Sep 30, 2017 −$39.01M
Net Income Q3 2018 · Sep 30, 2017 −$103.67M